Alfred Englert, Jr. v. HHS - Influenza, Guillain-Barré syndrome (2024)

Alfred Englert, Jr. filed a petition for compensation under the National Vaccine Injury Compensation Program, alleging that he developed Guillain-Barré syndrome (GBS) as a result of an influenza vaccine administered on October 11, 2021. The case was filed on February 14, 2024.

Respondent conceded that Mr. Englert is entitled to compensation, stating that he satisfied the criteria set forth in the Vaccine Injury Table and Qualifications and Aids to Interpretation for a GBS Table injury.

A ruling on entitlement was issued on February 14, 2024, finding Mr. Englert entitled to compensation.

Subsequently, on May 31, 2024, Respondent filed a proffer on award of compensation, which Mr. Englert agreed to.

The decision on damages was issued on July 1, 2024. The award included a lump sum payment of $512,170.03 for pain and suffering, past unreimbursable expenses, and past lost wages, payable to Mr.

Englert. Additionally, two joint payments were awarded: $1,778.04 to be paid jointly to Mr.

Englert and Texas Health Resources, and $300.00 to be paid jointly to Mr. Englert and Virtue Anesthesia.

These amounts represent compensation for all damages available under the Vaccine Act.